| Product NDC: | 55154-4518 |
| Proprietary Name: | AVANDIA |
| Non Proprietary Name: | rosiglitazone maleate |
| Active Ingredient(s): | 8 mg/1 & nbsp; rosiglitazone maleate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-4518 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021071 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990528 |
| Package NDC: | 55154-4518-4 |
| Package Description: | 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6) |
| NDC Code | 55154-4518-4 |
| Proprietary Name | AVANDIA |
| Package Description | 30 POUCH in 1 CARTON (55154-4518-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-4518-6) |
| Product NDC | 55154-4518 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rosiglitazone maleate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19990528 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | ROSIGLITAZONE MALEATE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |